EndoChoice (GI) Tops Q4 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/4/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Equities close higher as softer jobs data quiets rate-hike expectations
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Tanker struck by projectile in Strait of Hormuz
- AppLovin shares fall after court denies request against Unity
EndoChoice Announces Fourth Quarter and Full Year 2015 Financial Results and Provides Guidance for 2016
March 3, 2016 7:00 AM ESTALPHARETTA, Ga., March 3, 2016 /PRNewswire/ --Â EndoChoice Holdings, Inc. (NYSE:Â GI)Â announced today financial results for the fourth quarter and full year 2015.
2015 Highlights
Revenue of $72.3 million, up 18% year-over-year (20% in constant currency) Installed base of Fuse® reaches 123 systems; end user systems increased 116% in 2015. Pathology revenue up 10% year-over-year driven by 20% specimen growth and 18% customer growth International revenue up 11% year-over-year (33% in constant currency) Launched two new Single Use Products in 2015; four launches planned for 2016Mark Gilreath, Founder and Chief Executive Officer of EndoChoice, said, "In 2015 we made... More
